I.F. Gazi

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

Theodosios D. Filippatos, I.F. Gazi, Evangelos Liberopoulos et al. · Atherosclerosis · 2006 · 83 citations

Life Sciences, Pharmacology, Pharmacotherapy +14

Increased plasma visfatin levels in subjects with the metabolic syndrome

Theodosios D. Filippatos, Christos S. Derdemezis, I.F. Gazi et al. · European Journal of Clinical Investigation · 2007 · 83 citations

Life Sciences, Nutritional Sciences, Physiology +13

Alterations in the High Density Lipoprotein Phenotype and HDL‐Associated Enzymes in Subjects with Metabolic Syndrome

Konstantinos Lagos, Theodosios D. Filippatos, Vasilis Tsimihodimos et al. · Lipids · 2008 · 73 citations

Life Sciences, Biochemistry, Lipid Biochemistry +13

Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes

F. Apostolou, I.F. Gazi, Konstantinos Lagos et al. · Atherosclerosis · 2010 · 57 citations

Life Sciences, Immunology, Microbiology +12

The effects of orlistat and fenofibrate, alone or in combination, on high‐density lipoprotein subfractions and pre‐beta1‐HDL levels in obese patients with metabolic syndrome

Theodosios D. Filippatos, Evangelos Liberopoulos, Michael S. Kostapanos et al. · Diabetes Obesity and Metabolism · 2007 · 51 citations

Life Sciences, Endocrinology, Pharmacotherapy +17